{"transactions":[{"id":752463,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T22:03:22.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":36252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests as to one-third of the shares on each annual anniversary of the date of grant."}],"balance_after":36252,"derivative":{"exercise_price":5.43,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":36252},"source":{"system":"sec-edgar","filing":"0001172346-26-000004","document":"form4-06032026_100618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1172346/000117234626000004/form4-06032026_100618.xml","form_type":"4"}},{"id":752462,"issuer":{"id":6920,"kind":"organization","name":"CVRx, Inc."},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T22:03:22.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":29005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vests as to one-third of the shares on each annual anniversary of the date of grant."}],"balance_after":29005,"source":{"system":"sec-edgar","filing":"0001172346-26-000004","document":"form4-06032026_100618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172346/000117234626000004/form4-06032026_100618.xml","form_type":"4"}},{"id":878654,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-27T21:20:02.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":98000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":98000,"derivative":{"underlying":"Common Stock","underlying_shares":98000},"source":{"system":"sec-edgar","filing":"0000805928-26-000036","document":"wk-form4_1772227199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000036/wk-form4_1772227199.xml","form_type":"4"}},{"id":972066,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-12T21:06:19.000Z","date":"2025-12-10","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":30,"value":750000.0,"ownership":{"direct":true},"balance_after":63537,"source":{"system":"sec-edgar","filing":"0000805928-25-000171","document":"wk-form4_1765573574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000171/wk-form4_1765573574.xml","form_type":"4"}},{"id":975267,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-10T22:21:05.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":61463,"price":31.208,"value":1918137.304,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025. This sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025, in multiple transactions at $31.208 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":88537,"source":{"system":"sec-edgar","filing":"0000805928-25-000167","document":"wk-form4_1765405262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000167/wk-form4_1765405262.xml","form_type":"4"}},{"id":979700,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-05T21:06:55.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of shares that vested as of December 4, 2025 upon the attainment of certain performance criteria."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0000805928-25-000145","document":"wk-form4_1764968812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000145/wk-form4_1764968812.xml","form_type":"4"}},{"id":1191657,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-26T20:48:12.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":176300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 25, 2029 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 25, 2027 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 25, 2029 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 25, 2027 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":176300,"derivative":{"underlying":"Common Stock","underlying_shares":176300},"source":{"system":"sec-edgar","filing":"0000805928-25-000046","document":"wk-form4_1743022084.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000046/wk-form4_1743022084.xml","form_type":"4"}},{"id":1437477,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Performance Stock Units","published_at":"2024-08-09T20:20:03.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents the right to receive one share of Common Stock. PSUs will be eligible to be earned by the reporting person based on achievement with respect to an annualized absolute total shareholder return performance goal over a three year performance period beginning February 22, 2024 and ending February 22, 2027. The number of PSUs indicated reflects the \"target\" number of PSUs granted to the reporting person. The number of PSUs earned could range from 0% to 200% of such target number. The PSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the reporting person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance stock unit (\"PSU\") represents the right to receive one share of Common Stock. PSUs will be eligible to be earned by the reporting person based on achievement with respect to an annualized absolute total shareholder return performance goal over a three year performance period beginning February 22, 2024 and ending February 22, 2027. The number of PSUs indicated reflects the \"target\" number of PSUs granted to the reporting person. The number of PSUs earned could range from 0% to 200% of such target number. The PSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the reporting person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each performance stock unit (\"PSU\") represents the right to receive one share of Common Stock. PSUs will be eligible to be earned by the reporting person based on achievement with respect to an annualized absolute total shareholder return performance goal over a three year performance period beginning February 22, 2024 and ending February 22, 2027. The number of PSUs indicated reflects the \"target\" number of PSUs granted to the reporting person. The number of PSUs earned could range from 0% to 200% of such target number. The PSUs were granted pursuant to an inducement award agreement outside of the Issuer's Amended and Restated 2019 Long-Term Incentive Plan as a material inducement to the reporting person's acceptance of employment with the Issuer in accordance with NASDAQ Listing Rule 5635(c)(4)"}],"balance_after":450000,"derivative":{"underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0000950170-24-094782","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000095017024094782/ownership.xml","form_type":"4"}},{"id":352018,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:25:49.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1209,"price":100.7,"value":121746.3,"ownership":{"direct":true},"balance_after":45133,"source":{"system":"sec-edgar","filing":"0001415889-23-003899","document":"form4-03032023_120339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003899/form4-03032023_120339.xml","form_type":"4"}},{"id":352017,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-03-03T00:25:49.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":4942,"price":99.77,"value":493063.34,"ownership":{"direct":true},"balance_after":46342,"source":{"system":"sec-edgar","filing":"0001415889-23-003899","document":"form4-03032023_120339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003899/form4-03032023_120339.xml","form_type":"4"}},{"id":352762,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2023-02-22T23:46:04.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":37483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,494 on February 17, 2024, 12,494 on February 17, 2025, and 12,495 on February 17, 2026."}],"balance_after":37483,"derivative":{"exercise_price":106.24,"exercise_date":"2024-02-17","expiration_date":"2033-02-16","underlying":"Common Shares","underlying_shares":37483},"source":{"system":"sec-edgar","filing":"0001415889-23-003049","document":"form4-02222023_110249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003049/form4-02222023_110249.xml","form_type":"4"}},{"id":352761,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2023-02-22T23:46:04.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":9504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":51284,"source":{"system":"sec-edgar","filing":"0001415889-23-003049","document":"form4-02222023_110249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588923003049/form4-02222023_110249.xml","form_type":"4"}},{"id":364249,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-10T22:25:57.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":4000,"price":117.0003,"value":468001.2,"ownership":{"direct":true},"balance_after":41780,"source":{"system":"sec-edgar","filing":"0001415889-22-002844","document":"form4-03102022_020344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002844/form4-03102022_020344.xml","form_type":"4"}},{"id":364710,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:36:39.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1053,"price":118.1503,"value":124412.2659,"ownership":{"direct":true},"balance_after":45780,"source":{"system":"sec-edgar","filing":"0001415889-22-002189","document":"form4-03022022_040327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002189/form4-03022022_040327.xml","form_type":"4"}},{"id":364709,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-03-03T00:36:39.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":4505,"price":122.41,"value":551457.05,"ownership":{"direct":true},"balance_after":46833,"source":{"system":"sec-edgar","filing":"0001415889-22-002189","document":"form4-03022022_040327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922002189/form4-03022022_040327.xml","form_type":"4"}},{"id":365293,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2022-02-24T01:06:08.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":54280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,093 on February 18, 2023, 18,093 on February 18, 2024, and 18,094 on February 18, 2025."}],"balance_after":54280,"derivative":{"exercise_price":117.58,"exercise_date":"2023-02-18","expiration_date":"2032-02-17","underlying":"Common Shares","underlying_shares":54280},"source":{"system":"sec-edgar","filing":"0001415889-22-001733","document":"form4-02232022_050253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001733/form4-02232022_050253.xml","form_type":"4"}},{"id":365292,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2022-02-24T01:06:08.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":11647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":51338,"source":{"system":"sec-edgar","filing":"0001415889-22-001733","document":"form4-02232022_050253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588922001733/form4-02232022_050253.xml","form_type":"4"}},{"id":372983,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-07-30T21:21:44.000Z","date":"2021-07-28","kind":"exercise","acquired":false,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":50.72,"exercise_date":"2020-07-21","expiration_date":"2027-07-20","underlying":"Common Shares","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001415889-21-003748","document":"form4-07302021_020718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921003748/form4-07302021_020718.xml","form_type":"4"}},{"id":372982,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-07-30T21:21:44.000Z","date":"2021-07-28","kind":"sale","acquired":false,"shares":17600,"price":120.3342,"value":2117881.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.3203 to $120.35, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":39691,"source":{"system":"sec-edgar","filing":"0001415889-21-003748","document":"form4-07302021_020718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921003748/form4-07302021_020718.xml","form_type":"4"}},{"id":372981,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-07-30T21:21:44.000Z","date":"2021-07-28","kind":"exercise","acquired":true,"shares":17600,"price":50.72,"value":892672.0,"ownership":{"direct":true},"balance_after":57291,"source":{"system":"sec-edgar","filing":"0001415889-21-003748","document":"form4-07302021_020718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921003748/form4-07302021_020718.xml","form_type":"4"}},{"id":379027,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:13:57.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1475,"price":120.61,"value":177899.75,"ownership":{"direct":true},"balance_after":39691,"source":{"system":"sec-edgar","filing":"0001415889-21-001200","document":"form4-03022021_040334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001200/form4-03022021_040334.xml","form_type":"4"}},{"id":379026,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-03-03T00:13:57.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":4000,"price":121.58,"value":486320.0,"ownership":{"direct":true},"balance_after":41166,"source":{"system":"sec-edgar","filing":"0001415889-21-001200","document":"form4-03022021_040334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921001200/form4-03022021_040334.xml","form_type":"4"}},{"id":379671,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2021-02-23T23:41:11.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":53326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 17,775 on February 19, 2022, 17,775 on February 19, 2023, and 17,776 on February 19, 2024."}],"balance_after":53326,"derivative":{"exercise_price":124.04,"exercise_date":"2022-02-19","expiration_date":"2031-02-18","underlying":"Common Shares","underlying_shares":53326},"source":{"system":"sec-edgar","filing":"0001415889-21-000888","document":"form4-02232021_030249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000888/form4-02232021_030249.xml","form_type":"4"}},{"id":379670,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SENIOR VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2021-02-23T23:41:11.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":10403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":45166,"source":{"system":"sec-edgar","filing":"0001415889-21-000888","document":"form4-02232021_030249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588921000888/form4-02232021_030249.xml","form_type":"4"}},{"id":393948,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:21:39.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":787,"price":77.89,"value":61299.43,"ownership":{"direct":true},"balance_after":34763,"source":{"system":"sec-edgar","filing":"0001179110-20-002902","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002902/edgar.xml","form_type":"4"}},{"id":393947,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-03-03T22:21:39.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":2147,"price":79.19,"value":170020.93,"ownership":{"direct":true},"balance_after":35550,"source":{"system":"sec-edgar","filing":"0001179110-20-002902","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002902/edgar.xml","form_type":"4"}},{"id":394475,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Options (right to buy)","published_at":"2020-02-25T22:35:08.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":83818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,939 on February 21, 2021, 27,939 on February 21, 2022, and 27,940 on February 21, 2023."}],"balance_after":83818,"derivative":{"exercise_price":87.72,"exercise_date":"2021-02-21","expiration_date":"2030-02-20","underlying":"Common shares","underlying_shares":83818},"source":{"system":"sec-edgar","filing":"0001179110-20-002289","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002289/edgar.xml","form_type":"4"}},{"id":394474,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Commons shares without par value","published_at":"2020-02-25T22:35:08.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":37697,"source":{"system":"sec-edgar","filing":"0001179110-20-002289","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020002289/edgar.xml","form_type":"4"}},{"id":394921,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-19T22:53:30.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":396,"price":88.97,"value":35232.12,"ownership":{"direct":true},"balance_after":23947,"source":{"system":"sec-edgar","filing":"0001179110-20-001896","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020001896/edgar.xml","form_type":"4"}},{"id":394920,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":15392,"kind":"person","name":"DALE MICHAEL D","position":1,"cik":"0001172346","reported_name":"DALE MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2020-02-19T22:53:30.000Z","date":"2020-02-17","kind":"tax_withholding","acquired":false,"shares":951,"price":89.66,"value":85266.66,"ownership":{"direct":true},"balance_after":24343,"source":{"system":"sec-edgar","filing":"0001179110-20-001896","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000117911020001896/edgar.xml","form_type":"4"}}]}